Amgen Drug Wins US Approval for Advanced Small Cell Lung Cancer
(Bloomberg) -- Amgen Inc. won US approval for a new drug to treat a particularly aggressive form of advanced lung cancer, providing a badly needed new option for patients when chemotherapy stops working. Amgen’s drug is among the few treatments cleared for …